2020-03-25

Jieyihui——Experts live Q & A–Zero distance communication for patients with liver cancer

On Saturday, March 28th, the "Jieyihui" liver cancer special session, we specially invited three experts in the field of liver cancer to provide you with liver cancer treatment strategies and management methods to help you fight the epidemic and manage the disease in a special period.
2020-03-21

Jieyihui-Caring Together-Diabetes Friends in the Ncp Epidemic

How to manage diabetes in the new crown epidemic? Gitzo Pharma invites three experts and one diabetic who have worked in the field of diabetes for many years to share the diet and disease prevention of diabetic patients, precautions for drug treatment for diabetic patients, and clinical research on diabetes in epidemics.
2020-03-18

Bi Guiping, Deputy Mayor of Xuhui District, came to Jsure Health

On the afternoon of March 16, Bi Guiping, deputy head of Xuhui District, Shanghai, and his party came to Jsure Health to inspect and understand the company's production and operation, epidemic prevention and control, and resumption of production. Jsure Health CEO Lin Feng, Chief Operating Officer Qian Jun, and Vice President of Business Solutions Song Yi accompanied the visit and introduced the company's relevant situation.
2020-03-07

Jsure Health · Forum PI Connection Phase II-Clinical Study of IBD (Inflammatory Bowel Disease) in Epidemic Situation-Challenges and Opportunities

IBD clinical trials are prone to problems such as poor patient compliance and difficult management due to disease. At present, the new crown epidemic has a great impact on non-epidemic-related clinical trials. To this end, Jsure Health invites three experts who have worked in the field of gastrointestinal digestive clinical research for your subjects and operation management in IBD clinical trials provide reference experience.

Events

  • Jieyihui——Experts live Q & A–Zero distance communication for patients with liver cancer
    On Saturday, March 28th, the "Jieyihui" liver cancer special session, we specially invited three experts in the field of liver cancer to provide you with liver cancer treatment strategies and management methods to help you fight the epidemic and manage the disease in a special period.
  • Jieyihui-Caring Together-Diabetes Friends in the Ncp Epidemic
    How to manage diabetes in the new crown epidemic? Gitzo Pharma invites three experts and one diabetic who have worked in the field of diabetes for many years to share the diet and disease prevention of diabetic patients, precautions for drug treatment for diabetic patients, and clinical research on diabetes in epidemics.
  • Bi Guiping, Deputy Mayor of Xuhui District, came to Jsure Health
    On the afternoon of March 16, Bi Guiping, deputy head of Xuhui District, Shanghai, and his party came to Jsure Health to inspect and understand the company's production and operation, epidemic prevention and control, and resumption of production. Jsure Health CEO Lin Feng, Chief Operating Officer Qian Jun, and Vice President of Business Solutions Song Yi accompanied the visit and introduced the company's relevant situation.
  • Jsure Health · Forum PI Connection Phase II-Clinical Study of IBD (Inflammatory Bowel Disease) in Epidemic Situation-Challenges and Opportunities
    IBD clinical trials are prone to problems such as poor patient compliance and difficult management due to disease. At present, the new crown epidemic has a great impact on non-epidemic-related clinical trials. To this end, Jsure Health invites three experts who have worked in the field of gastrointestinal digestive clinical research for your subjects and operation management in IBD clinical trials provide reference experience.
  • Jsure Health · Forum PI Connected Phase 1——Group of three, Strategy and Design of Clinical Trials from NCP
    Jsure Health live broadcast new column: Jsure Health forum-PI connection Three experts who have been working in the field of clinical research for many years are invited. They are a doctor, a scientist, and a statistician. The three of them formed a special discussion on the design and analysis of clinical trials from three perspectives: experimental ethical principles, experimental design strategies, classic cases, and statistics.